ORLACIN Trademark

Trademark Overview

On Monday, June 6, 2011, a trademark application was filed for ORLACIN with the United States Patent and Trademark Office. The USPTO has given the ORLACIN trademark a serial number of 85338854. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 2, 2015. This trademark is owned by Glaxo Group Limited. The ORLACIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
orlacin

General Information

Serial Number85338854
Word MarkORLACIN
Filing DateMonday, June 6, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 2, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 9, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, February 2, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 2, 2015ABANDONMENT - NO USE STATEMENT FILED
Wednesday, June 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 3, 2014EXTENSION 5 GRANTED
Thursday, May 22, 2014EXTENSION 5 FILED
Thursday, May 22, 2014TEAS EXTENSION RECEIVED
Tuesday, January 14, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 13, 2014EXTENSION 4 GRANTED
Wednesday, December 11, 2013EXTENSION 4 FILED
Wednesday, December 11, 2013TEAS EXTENSION RECEIVED
Saturday, July 20, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 19, 2013EXTENSION 3 GRANTED
Wednesday, June 19, 2013EXTENSION 3 FILED
Friday, July 19, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 1, 2013ASSIGNED TO EXAMINER
Wednesday, June 19, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 14, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 13, 2012EXTENSION 2 GRANTED
Thursday, December 6, 2012EXTENSION 2 FILED
Thursday, December 13, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 6, 2012TEAS EXTENSION RECEIVED
Wednesday, June 27, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 25, 2012EXTENSION 1 GRANTED
Monday, June 25, 2012EXTENSION 1 FILED
Monday, June 25, 2012TEAS EXTENSION RECEIVED
Tuesday, December 27, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 1, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 1, 2011PUBLISHED FOR OPPOSITION
Thursday, September 22, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 20, 2011ASSIGNED TO EXAMINER
Thursday, June 9, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 9, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

orlacin pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological